About GSK
GSK is a company based in Plymouth (United States) founded in 2022 by Nicholas Lydon, George Demetri, and Alexis Borisy was acquired by GSK in January 2025. It operates as a Direct-to-Consumer (D2C), and Professional Services. GSK has raised $242 million across 2 funding rounds from investors including Blackstone, Merck and RA Capital. GSK offers products and services including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions. GSK operates in a competitive market with competitors including Intima Bioscience, Shgsmed.com, Draconis Pharma, Ilico Genetics and Checkmate Therapeutics, among others.
- Headquarter Plymouth, United States
- Founders Nicholas Lydon, George Demetri, Alexis Borisy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gsk Plc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$242 M (USD)
in 2 rounds
-
Latest Funding Round
$120 M (USD), Series B
Aug 07, 2024
-
Investors
Blackstone
& 10 more
-
Employee Count
Employee Count
-
Acquired by
GSK
(Jan 08, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GSK
GSK offers a comprehensive portfolio of products and services, including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Solutions for respiratory conditions are developed and provided.
Cancer treatments are researched and offered for patients.
HIV therapies are created to manage the condition.
Treatments for infectious diseases are developed and distributed.
Unlock access to complete
Unlock access to complete
Funding Insights of GSK
GSK has successfully raised a total of $242M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $120 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $120.0M
-
First Round
First Round
(02 Aug 2022)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series B - GSK | Valuation | RA Capital Management | |
| Aug, 2022 | Amount | Series A - GSK | Valuation | a16z , Casdin Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GSK
GSK has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Blackstone, Merck and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to healthcare startups by Commodore Capital.
|
Founded Year | Domain | Location | |
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GSK
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GSK
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gsk Comparisons
Competitors of GSK
GSK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intima Bioscience, Shgsmed.com, Draconis Pharma, Ilico Genetics and Checkmate Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing.
|
|
| domain | founded_year | HQ Location |
Drugs for esophageal cancer treatment are developed using photodynamic therapy.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for cancer, pain, and immune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagostic test for detection of gastric cancer
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutic technologies for cancer and neurological disorders.
|
|
| domain | founded_year | HQ Location |
Develops innovative technologies for anticancer therapies targeting gastrointestinal cancers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gsk
Frequently Asked Questions about GSK
When was GSK founded?
GSK was founded in 2022.
Where is GSK located?
GSK is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Is GSK a funded company?
GSK is a funded company, having raised a total of $242M across 2 funding rounds to date. The company's 1st funding round was a Series A of $122M, raised on Aug 02, 2022.
What does GSK do?
GSK, a leading biopharmaceutical company, is focused on uniting science, technology, and talent to address diseases. Operations are centered in therapeutic areas such as respiratory, immunology, oncology, HIV, and infectious diseases. Solutions are developed to improve global health access, particularly in lower-income regions. Commitment is shown towards environmental sustainability and ethical standards. Research and development efforts are prioritized to innovate treatments and positively impact 2.5 billion people by the decades end.
Who are the top competitors of GSK?
GSK's top competitors include Draconis Pharma, Ilico Genetics and Intima Bioscience.
What products or services does GSK offer?
GSK offers Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.
Who are GSK's investors?
GSK has 11 investors. Key investors include Blackstone, Merck, RA Capital, GSK, and Commodore Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.